Institutional members access full text with Ovid®

Share this article on:

Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials

Noordzij, Marliesa; Uiterwaal, Cuno SPMb; Arends, Lidia Rc; Kok, Frans Ja; Grobbee, Diederick Eb; Geleijnse, Johanna Ma

Meta-analysis

Purpose: Coffee is a widely consumed beverage and small health effects of substances in coffee may have large public health consequences. It has been suggested that caffeine in coffee increases the risk of hypertension. We performed a meta-analysis of randomized controlled trials of coffee or caffeine and blood pressure (BP).

Data identification: BP trials of coffee or caffeine published between January 1966 and January 2003 were identified through literature databases and manual serach.

Study selection: A total of 16 studies with a randomized, controlled design and at least 7 days of intervention was selected, comprising 25 strata and 1010 subjects.

Data extraction: Two persons independently obtained data on sample size, type and duration of intervention, changes in BP and heart rate (HR), and subjects’ characteristics for each trial. Meta-analysis was performed using a random-effects model.

Results: A significant rise of 2.04 mmHg [95% confidence interval (CI), 1.10–2.99] in systolic BP and 0.73 mmHg (95% CI, 0.14–1.31) in diastolic BP was found after pooling of coffee and caffeine trials. When coffee trials (n = 18, median intake: 725 ml/day) and caffeine trials (n = 7, median dose: 410 mg/day) were analysed separately, BP elevations appeared to be larger for caffeine [systolic: 4.16 mmHg (2.13–6.20); diastolic: 2.41 mmHg (0.98–3.84)] than for coffee [systolic: 1.22 mmHg (0.52–1.92) and diastolic: 0.49 mmHg (−0.06–1.04)]. Effects on HR were negligible.

Conclusions: Regular caffeine intake increases BP. When ingested through coffee, however, the blood pressure effect of caffeine is small.

aDivision of Human Nutrition, Wageningen University, Wageningen

bJulius Center for Health Sciences and Primary Care, Utrecht University, Utrecht

cDepartment of Epidemiology and Biostatistics, Erasmus University Rotterdam, Rotterdam, The Netherlands

Received 13 August, 2004

Revised 19 January, 2005

Accepted 9 February, 2005

Correspondence and requests for reprints to Dr J.M. Geleijnse, Wageningen University, Division of Human Nutrition, PO Box 8129, 6700 EV Wageningen, The Netherlands. Tel: +31 317 48 2574; fax: +31 317 48 3342; e-mail: marianne.geleijnse@wur.nl

© 2005 Lippincott Williams & Wilkins, Inc.